Article Details
Retrieved on: 2025-02-25 13:30:42
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the growth of the Antibody Drug Conjugates (ADC) market in biopharma, emphasizing advancements in biotechnology and partnerships such as Sutro Biopharma and Daiichi Sankyo. It aligns with the tags related to immunology and genetic engineering.
Article found on: www.openpr.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here